Randall Children's Hospital at Legacy Emanuel

Portland, Oregon 97227

2 studies enrolling now · 9 studies all time

What they study most

Arthritis, Juvenile Idiopathic, Central Nervous System Tumor, Pediatric, Chemotherapy-induced Nausea and Vomiting, Ewing Sarcoma, Hunter Syndrome, Juvenile Idiopathic Arthritis, Juvenile Spondyloarthritis, Non-rhabdomyosarcoma Soft Tissue Sarcoma, Polyarticular Juvenile Rheumatoid Arthritis, Relapsed/Refractory Rhabdomyosarcoma, Rheumatic Joint Disease, Unspecified Childhood Solid Tumor, Protocol Specific

Studies at this site

• Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry — Recruiting now
• Biologic Abatement and Capturing Kids' Outcomes and Flare Frequency in Juvenile Spondyloarthritis — Completed
• Post-trial Access Program of Idursulfase-IT Along With Elaprase in Children With Hunter Syndrome — Available (expanded access)
• Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis — Completed
• Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Participants With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EWS) — Completed
• Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy — Completed
• Start Time Optimization of Biologics in Polyarticular JIA — Completed
• Efficacy Study Of Tofacitinib In Pediatric JIA Population — Completed
• Pharmacokinetics Of CP-690,550 In Pediatric Patients With Juvenile Idiopathic Arthritis (JIA) — Completed